Search
Electra Therapeutics Ord Shs
ETRAAdd to Watchlist
15.000
0.000--
Close 09-22 16:00（ET）
--Market Cap
--P/E TTM
About Electra Therapeutics Ord Shs Company
Electra Therapeutics Inc is a United States-based clinical- stage biotechnology company. The Company is developing therapies that target signal regulatory proteins (SIRP) for the treatment of immunological diseases and cancer. Its ELA026, is a monoclonal antibody that targets SIRP on the cell surface of myeloid and T cells and precisely depletes pathological immune cells.
Electra Therapeutics Ord Shs Profile
Ticker SymbolETRA
Company nameElectra Therapeutics, Inc.
IPO dateSep 18, 2026
CEODong (Quehuong)
Number of employees- -
Security typeOrdinary Share
Fiscal year-end- -
Address230 E Grand Avenue,
CitySOUTH SAN FRANCISCO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code94080
Phone18887432290
Websitehttps://electra-therapeutics.com
Ticker SymbolETRA
IPO dateSep 18, 2026
CEODong (Quehuong)
Company Executives of Electra Therapeutics Ord Shs
Name
Name/Position
Position
Shareholding
Change
Relevant data have not been disclosed by the company yet.
Name
Name/Position
Position
Shareholding
Change
Relevant data have not been disclosed by the company yet.